Literature DB >> 30923830

Genome-wide identification of the essential protein-coding genes and long non-coding RNAs for human pan-cancer.

Yuwei Zhang1, Yang Tao1, Huihui Ji2, Wei Li3, Xingli Guo4, Derry Minyao Ng1, Maria Haleem1, Yang Xi2, Changzheng Dong1, Jinshun Zhao1, Lina Zhang1, Xiaohong Zhang1, Yangyang Xie5, Xiaoyu Dai5, Qi Liao1.   

Abstract

MOTIVATION: Genome-scale CRISPR/Cas9 system has been a democratized gene editing technique and widely used to investigate gene functions in some biological processes and diseases especially cancers. Aiming to characterize gene aberrations and assess their effects on cancer, we designed a pipeline to identify the essential genes for pan-cancer.
METHODS: CRISPR screening data were used to identify the essential genes that were collected from published data and integrated by Robust Rank Aggregation algorithm. Then, hypergeometrics test and random walks with restart (RWR) were used to predict additional essential genes on broader scale. Finally, the expression status and potential roles of these genes were explored based on TCGA portal and regulatory network analysis.
RESULTS: We collected 926 samples from 10 CRISPR-based screening studies involving 33 different types of cancer to identify cancer-essential genes, which consists of 799 protein-coding genes (PCGs) and 97 long non-coding RNAs (lncRNAs). Then, we constructed a 'bi-colored' network with both PCGs and lncRNAs and applied it to predict additional essential genes including 495 PCGs and 280 lncRNAs on a broader scale using hypergeometrics test and RWR. After obtaining all essential genes, we further investigated their potential roles in cancer and found that essential genes have higher and more stable expression levels, and are associated with multiple cancer-associated biological processes and survival time. The regulatory network analysis detected two intriguing modules of essential genes participating in the regulation of cell cycle and ribosome biogenesis in cancer.
AVAILABILITY AND IMPLEMENTATION: . SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30923830     DOI: 10.1093/bioinformatics/btz230

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  5 in total

1.  Clinical significance of ring finger protein 2 high expression in skin squamous cell carcinoma.

Authors:  Bai Ling; Ming Yao; Gongqi Li; Jun Liu; Bin Liu; Wei Wang; Bin Jiang
Journal:  Oncol Lett       Date:  2020-05-22       Impact factor: 2.967

2.  Function and regulation annotation of up-regulated long non-coding RNA LINC01234 in gastric cancer.

Authors:  Yinyin Zhu; Cong Luo; Arshad Ali Korakkandan; Yislam Hadi Ahmed Fatma; Yang Tao; Tianfei Yi; Shiyun Hu; Qi Liao
Journal:  J Clin Lab Anal       Date:  2020-02-03       Impact factor: 2.352

3.  ncFANs v2.0: an integrative platform for functional annotation of non-coding RNAs.

Authors:  Yuwei Zhang; Dechao Bu; Peipei Huo; Zhihao Wang; Hao Rong; Yanguo Li; Jingjia Liu; Meng Ye; Yang Wu; Zheng Jiang; Qi Liao; Yi Zhao
Journal:  Nucleic Acids Res       Date:  2021-07-02       Impact factor: 16.971

4.  Development of a four-gene prognostic model for pancreatic cancer based on transcriptome dysregulation.

Authors:  Jie Yan; Liangcai Wu; Congwei Jia; Shuangni Yu; Zhaohui Lu; Yueping Sun; Jie Chen
Journal:  Aging (Albany NY)       Date:  2020-02-20       Impact factor: 5.682

5.  A four-gene signature associated with clinical features can better predict prognosis in prostate cancer.

Authors:  Penghui Yuan; Le Ling; Qing Fan; Xintao Gao; Taotao Sun; Jianping Miao; Xianglin Yuan; Jihong Liu; Bo Liu
Journal:  Cancer Med       Date:  2020-09-13       Impact factor: 4.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.